ATENOLOL Drug Patent Profile
✉ Email this page to a colleague
When do Atenolol patents expire, and what generic alternatives are available?
Atenolol is a drug marketed by Able, Apothecon, Aurobindo Pharma, Chartwell Rx, Hlthcare, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, SCS, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Twi Pharms, Unichem, Unique, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Aurobindo Pharma Usa, Novitium Pharma, and Zydus Pharms. and is included in thirty-nine NDAs.
The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atenolol
A generic version of ATENOLOL was approved as atenolol; chlorthalidone by TWI PHARMS on May 31st, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATENOLOL?
- What are the global sales for ATENOLOL?
- What is Average Wholesale Price for ATENOLOL?
Summary for ATENOLOL
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 39 |
| Finished Product Suppliers / Packagers: | 32 |
| Raw Ingredient (Bulk) Api Vendors: | 163 |
| Clinical Trials: | 118 |
| Patent Applications: | 4,430 |
| Drug Prices: | Drug price information for ATENOLOL |
| Drug Sales Revenues: | Drug sales revenues for ATENOLOL |
| DailyMed Link: | ATENOLOL at DailyMed |
Recent Clinical Trials for ATENOLOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Zagazig University | Phase 2 |
| Ain Shams University | Phase 4 |
| Sundeep Khosla, M.D. | Phase 3 |
Pharmacology for ATENOLOL
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for ATENOLOL
Anatomical Therapeutic Chemical (ATC) Classes for ATENOLOL
US Patents and Regulatory Information for ATENOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 073582-002 | Apr 29, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | ATENOLOL | atenolol | TABLET;ORAL | 073475-001 | Mar 30, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Scs | ATENOLOL | atenolol | TABLET;ORAL | 073676-001 | Oct 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms | ATENOLOL | atenolol | TABLET;ORAL | 074120-002 | Feb 24, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs Teva | ATENOLOL | atenolol | TABLET;ORAL | 073353-001 | Dec 27, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
